Stifel Financial’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.45M Buy
19,970
+3,874
+24% +$669K ﹤0.01% 1466
2025
Q1
$2.51M Sell
16,096
-1,001
-6% -$156K ﹤0.01% 1605
2024
Q4
$2.35M Buy
17,097
+4,534
+36% +$624K ﹤0.01% 1653
2024
Q3
$1.88M Sell
12,563
-544
-4% -$81.2K ﹤0.01% 1819
2024
Q2
$1.79M Sell
13,107
-53
-0.4% -$7.23K ﹤0.01% 1794
2024
Q1
$1.99M Buy
13,160
+579
+5% +$87.5K ﹤0.01% 1721
2023
Q4
$1.58M Sell
12,581
-12
-0.1% -$1.51K ﹤0.01% 1828
2023
Q3
$1.18M Buy
12,593
+2,941
+30% +$275K ﹤0.01% 1935
2023
Q2
$861K Buy
9,652
+484
+5% +$43.2K ﹤0.01% 2174
2023
Q1
$983K Sell
9,168
-205
-2% -$22K ﹤0.01% 2074
2022
Q4
$1.14M Buy
9,373
+586
+7% +$71.6K ﹤0.01% 1896
2022
Q3
$907K Buy
8,787
+497
+6% +$51.3K ﹤0.01% 2039
2022
Q2
$771K Buy
8,290
+12
+0.1% +$1.12K ﹤0.01% 2185
2022
Q1
$972K Sell
8,278
-165
-2% -$19.4K ﹤0.01% 2133
2021
Q4
$1.14M Buy
8,443
+954
+13% +$128K ﹤0.01% 2035
2021
Q3
$1.19M Buy
7,489
+962
+15% +$153K ﹤0.01% 1949
2021
Q2
$859K Sell
6,527
-89
-1% -$11.7K ﹤0.01% 2214
2021
Q1
$853K Sell
6,616
-42
-0.6% -$5.42K ﹤0.01% 2097
2020
Q4
$1.11M Sell
6,658
-56
-0.8% -$9.34K ﹤0.01% 1768
2020
Q3
$1.04M Buy
6,714
+268
+4% +$41.4K ﹤0.01% 1603
2020
Q2
$953K Sell
6,446
-335
-5% -$49.5K ﹤0.01% 1589
2020
Q1
$762K Buy
6,781
+69
+1% +$7.75K ﹤0.01% 1601
2019
Q4
$933K Buy
6,712
+2,509
+60% +$349K ﹤0.01% 1882
2019
Q3
$407K Buy
4,203
+1,616
+62% +$156K ﹤0.01% 2275
2019
Q2
$295K Sell
2,587
-147
-5% -$16.8K ﹤0.01% 2510
2019
Q1
$323K Buy
+2,734
New +$323K ﹤0.01% 2314